We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CALL
Armstrong World Industries
AWI
$7.38B
| $13.6M | 0.68% |
139,500
+64,500
| +86% | +$5.77M |
|
|
CTLP
27
CALL
DELISTED
Cantaloupe
CTLP
| $12.8M | 0.65% |
1,724,600
+1,344,600
| +354% | +$8.33M |
|
|
AVYA
28
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $12.5M | 0.63% |
+1,047,900
| New | +$16M |
|
29
PUT
Viatris
VTRS
$20.4B
| $12.2M | 0.61% |
639,600
+203,500
| +47% | +$4.5M |
|
30
CALL
Lennar Class A
LEN
$19.8B
| $12.1M | 0.61% |
+258,250
| New | +$12.9M |
|
31
CALL
Sarepta Therapeutics
SRPT
$1.57B
| $11.8M | 0.6% |
77,900
+67,900
| +679% | +$8.25M |
|
|
GWPH
32
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11.4M | 0.57% |
+66,000
| New | +$11.4M |
|
|
33
CALL
O'Reilly Automotive
ORLY
$72.9B
| $11.1M | 0.56% |
+450,000
| New | +$11.4M |
|
34
PUT
PG&E
PCG
$38.3B
| $11.1M | 0.56% |
482,900
-275,600
| -36% | -$5.54M |
|
35
CALL
Centene
CNC
$30.7B
| $10.8M | 0.55% |
206,600
-63,400
| -23% | -$3.42M |
|
36
CALL
DaVita
DVA
$15.4B
| $10.2M | 0.51% |
+181,600
| New | +$9.41M |
|
37
CALL
Burlington
BURL
$23.2B
| $10.2M | 0.51% |
+60,000
| New | +$9.81M |
|
38
CALL
Devon Energy
DVN
$52.1B
| $10.2M | 0.51% |
+357,300
| New | +$10.6M |
|
39
PUT
Travere Therapeutics
TVTX
$5.2B
| $10.1M | 0.51% |
+501,000
| New | +$9.89M |
|
|
DCPH
40
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.65M | 0.49% |
+427,900
| New | +$10M |
|
41
CALL
Planet Fitness
PLNT
$4.42B
| $9.62M | 0.48% |
132,800
+7,800
| +6% | +$588K |
|
|
42
PUT
Planet Fitness
PLNT
$4.42B
| $9.62M | 0.48% |
132,800
+7,800
| +6% | +$588K |
|
|
CRC
43
CALL
DELISTED
California Resources Corporation
CRC
| $9.47M | 0.48% |
481,300
+361,300
| +301% | +$7.69M |
|
|
44
CALL
Viatris
VTRS
$20.4B
| $9.2M | 0.46% |
483,000
+96,900
| +25% | +$2.14M |
|
45
CALL
Gaming and Leisure Properties
GLPI
$12.7B
| $8.85M | 0.45% |
+227,100
| New | +$9M |
|
46
CALL
Target
TGT
$65.6B
| $8.66M | 0.44% |
100,000
| – | – |
|
|
BPMC
47
CALL
DELISTED
Blueprint Medicines
BPMC
| $8.61M | 0.43% |
+91,300
| New | +$7.54M |
|
|
WCG
48
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $8.55M | 0.43% |
+30,000
| New | +$8.27M |
|
49
PUT
Cigna
CI
$73.7B
| $8.47M | 0.43% |
53,800
| – | – |
|
50
PUT
Sunrun
RUN
$2.34B
| $8.44M | 0.43% |
+450,000
| New | +$7.32M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.